v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Beginning balance, shares outstanding (in shares) at Dec. 31, 2024   664,224,893      
Beginning balance at Dec. 31, 2024 $ 874,402 $ 664 $ 328,538 $ (765) $ 545,965
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income 465       465
Issuance of shares upon exercise of stock options and vesting of restricted stock units (in shares)   1,485,913      
Issuance of shares upon exercise of stock options and vesting of restricted stock units 527 $ 2 525    
Share-based compensation expense 2,918   2,918    
Unrealized gain on derivatives, net of tax expense 17     17  
Ending balance, shares outstanding (in shares) at Mar. 31, 2025   665,710,806      
Ending balance at Mar. 31, 2025 $ 878,329 $ 666 331,981 (748) 546,430
Beginning balance, shares outstanding (in shares) at Dec. 31, 2025 669,076,651 669,076,651      
Beginning balance at Dec. 31, 2025 $ 879,390 $ 669 342,345 (337) 536,713
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income (5,287)       (5,287)
Issuance of shares upon exercise of stock options and vesting of restricted stock units (in shares)   2,634,942      
Issuance of shares upon exercise of stock options and vesting of restricted stock units 227 $ 3 224    
Share-based compensation expense 3,517   3,517    
Unrealized gain on derivatives, net of tax expense $ 139     139  
Ending balance, shares outstanding (in shares) at Mar. 31, 2026 671,711,593 671,711,593      
Ending balance at Mar. 31, 2026 $ 877,986 $ 672 $ 346,086 $ (198) $ 531,426